Serotonin reduction in post-acute sequelae of viral infection
Peripheral serotonin reduction, in turn, impedes the activity of the vagus nerve and impairs hippocampal responses and memory. These findings provide a possible explanation for neurocognitive symptoms associated with viral persistence in Long COVID.
9th Influenza Conference 2023
The Ninth ESWI Influenza Conference: Highlights
ESWI 2023: 10 key take home messages
Benefits of ensitrelvir in Covid-19 and long Covid highlighted in two studies
The benefits of ensitrelvir use in patients with symptoms of long Covid and as a second-line treatment option for those hospitalised with Covid-19.
International scientific community gathers in Valencia for the 9th ESWI Conference on Influenza, COVID-19, and RSV
Since it was established 30 years ago, the European Scientific Working Group on Influenza and other Acute Respiratory Viruses (ESWI) is hosting the 9TH ESWI Influenza Conference
Long Covid: clues about causes
This investigated the monocyte and inflammatory profiles of individuals who were hospitalised with COVID-19 during the acute phase and the convalescent period.
Toward Comprehensive Care for Long Covid
The sequelae of SARS-CoV-2 infection can involve multiple organ systems and are often grouped together as “long Covid” or PASC (postacute sequelae of SARS-CoV-2)
ESWI Airborne: Burden of Disease
Burden of disease - Long-Covid and other post-infection syndromes
What do we know about long-Covid? In this captivating episode we listen to the personal and powerful account of how the lingering effects of Sars-CoV-2 has wreaked havoc in an otherwise healthy person.
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
What symptoms are differentially present in SARS-CoV-2–infected individuals 6 months or more after infection compared with uninfected individuals? What symptom-based criteria can be used to identify postacute sequelae of SARS-CoV-2 infection cases?
Prevention of long COVID: progress and challenges
Long COVID—the umbrella term that encompasses the post-acute and long-term sequelae of SARS-CoV-2 infection—can be profoundly disabling and might affect people for a lifetime.
Policy & Recommendations
EU Ministers of Health expressed their full support for the EU Global Health Strategy
The strategy, presented by the European Commission on 30 November 2022, puts global health forward as an essential pillar of EU external policy
EU-US conference on Long COVID
This online conference aimed to shed light on perspectives for addressing long COVID in the EU and the US. It brought together experts from medical, public health, health economics disciplines, patient organisations and policymakers.
Two-Years Follow-Up of Symptoms and Return to Work in Complex Post-COVID-19 Patients
Many COVID-19 patients present with severe long-lasting symptoms. They might benefit from a coordination team to manage such complex situations, but late efficacy still needs to be determined.